Statistics from Altmetric.com
Question In schizophrenia, to what extent does chlorpromazine reduce symptoms, relapse, and discontinuation of medication, and how frequent are the most common adverse events?
Studies were identified by searching Biological Abstracts, Cochrane Schizophrenia Group's Register, The Cochrane Library, EMBASE, Medline, PsycLIT, and SCISEARCH; by scanning the bibliographies of identified articles; and by contacting pharmaceutical companies and authors of trials.
Studies were selected if they were randomised controlled trials investigating the effectiveness of chlorpromazine compared with placebo or no treatment in patients with schizophrenia.
Data were extracted on patient characteristics, drug dose, and primary outcomes of interest: death, relapse, overall improvement, discontinuation …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.